Collectively, the characteristics of the various monogenic defects and the temporary response to SU therapy observed in type 2 diabetes suggest that multiple processes downstream of mitochondrial metabolism and the KATP channel within the pancreatic beta cell, that regulate the amplification response to glucose or insulin exocytosis itself are most likely involved in the progression of type 2 diabetes [12]. Here, INS is linked to type 2 diabetes mellitus.